These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18284001)

  • 21. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
    Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
    Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.
    Kielstein JT; Burkhardt O
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2015-9. PubMed ID: 21554216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma aluminum levels during sucralfate prophylaxis for stress ulceration in critically ill patients on continuous venovenous hemofiltration: a randomized, controlled trial.
    Mulla H; Peek G; Upton D; Lin E; Loubani M
    Crit Care Med; 2001 Feb; 29(2):267-71. PubMed ID: 11246304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
    Bellomo R; McGrath B; Boyce N
    Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
    Ikawa K; Morikawa N; Ikeda K; Suyama H
    J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of favipiravir during continuous venovenous haemofiltration in a critically ill patient with influenza.
    Favié LM; Murk JL; Meijer A; Nijstad AL; van Maarseveen EM; Sikma MA
    Antivir Ther; 2018; 23(5):457-461. PubMed ID: 29185991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of separated system continuous venovenous hemofiltration in critical acute kidney injury.
    Susantitaphong P; Tiranathanagul K; Srisawat N; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Oct; 15(5):475-80. PubMed ID: 21974701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
    Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
    J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
    Gao C; Tong J; Yu K; Sun Z; An R; Du Z
    Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways.
    Salmon J; Cardigan R; Mackie I; Cohen SL; Machin S; Singer M
    Intensive Care Med; 1997 Jan; 23(1):38-43. PubMed ID: 9037638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].
    Wang H; Cui N; Zhou YK; Cheng W; Li L; Long Y; Liu DW
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):285-289. PubMed ID: 29614588
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury.
    Shahbazi F; Shojaei L; Farvadi F; Kadivarian S
    Expert Rev Clin Pharmacol; 2022 May; 15(5):551-561. PubMed ID: 35734940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium.
    Bakker AJ; Boerma EC; Keidel H; Kingma P; van der Voort PH
    Clin Chem Lab Med; 2006; 44(8):962-6. PubMed ID: 16879061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.